ACET FY 2021 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-45.7% YoY

Gross Profit

$10M100.0% margin

Operating Income

-$61M-631.4% margin

Net Income

-$62M-637.2% margin

EPS (Diluted)

$-32.00

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$64M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$339M

Total Liabilities

$36M

Stockholders' Equity

$303M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$18M	-45.7%
Gross Profit	$10M	$18M	-45.7%
Operating Income	-$61M	-$39M	-56.8%
Net Income	-$62M	-$37M	-69.0%